AbbVie’s Humira loss of exclusivity a missed opportunity for competitors: GlobalData GlobalData Jul 16, 2024 Strategic shift to Skyrizi and Rinvoq strengthens AbbVie's dominance in immunology despite Humira's biosimilar competition
